IVC Filter Lawsuits: Manufacturers Deluged by Product Liability Lawsuits

Written by admin

Many cases have been filed against the manufacturers of IVC fiters because of its high failure rates. The lawsuits accuses the manufacturers of faulty filters which punctured veins, blood vessels and filter migrated to different parts of the body causing several life threatening complications and injuries. The broken parts of IVC Filter can punctured organs and migrate throughout the body, causing embolisms, strokes, and other serious complications. In recent years, a number of studies have raised serious concerns about the risk of perforation. This complication occurs when IVC filters are left in place after the risk of pulmonary embolism has passed. The FDA safety communication states that the risk of device perforation greatly increased the longer the device stayed in the body and recommending they be removed after 39 days, but before 54 days. Unfortunately, less than 20% are ever removed.

Thousand of Lawsuits are facing by the manufacturers of IVC filters. As of November 2016 more than 1,100 IVC filter lawsuits were pending against C.R. Bard in Multi-District Litigation (MDL No. 2641) and currently there are at least 3 IVC filter class action lawsuits pending against Bard Medical in California, Pennsylvania and Florida. Recently a woman from Alabama filed a personal injury and defective product liability lawsuit against C.R. Bard Eclipse® Vena Cava Filter. She has claimed in her lawsuit that she was the recipient of an Eclipse IVC filter manufactured by C.R. Bard. It was implanted into her body on January 13, 2011 in order to protect her from blood clots which could migrate toward her heart and lungs. The woman was at risk of suffering pulmonary embolism or other major health problems. The lawsuit was filed on November 18, 2016 in the U.S. District Court for the District of Arizona under the Case No. 2:16-cv-04001 and was represented by Ben C. Martin of The Law Offices of Ben C. Martin in Dallas, Texas.

The Bard Recovery Filter is a medical device created by C.R. Bard, Inc. and approved by FDA in 2002 to prevent blood clots from traveling through the body and causing a pulmonary embolism. The device is implanted in individuals at risk for a pulmonary embolism, who are unable to take an anticoagulant or if such medications have failed. The Bard Recovery is designed so that the IVC filter can be removed or retrieved from the body after the threat of a pulmonary embolism has passed. In recent years, a number of studies have raised serious concerns about the risk of Bard IVC filter perforation. A study published in the Archives of Internal Medicine in 2010 found that the rate of complications with Bard Recovery IVC filters was 25%, with researchers finding that pieces of the Bard Recovery Filter migrated to the heart in more than 70% of those who experienced a fracture. In a study published in 2014 the fracture-risk was estimated at 38% within 5.5 years.

Thousands of lawsuits accuses the manufacturer of concealing known risks, failing to warn about IVC filter side effects, and continuing to market the filter as safe and effective despite a lack of studies proving its long-term or short-term safety. If you or someone you love suffered complications or death from any of Bard’s IVC Filters (including the Eclipse ®) Contact All cases are pursued on a contingency fee basis there are never any out-of-pocket costs to hire our Cook filter attorneys unless we win your case. The Medical Device Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Bard Eclipse IVC Filter Lawsuits.

About the author


Leave a Comment